Overview
Melissa Cullingford is a Nurse Practitioner in Lowell, Massachusetts. Ms. Cullingford is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Smoldering Multiple Myeloma, Gallbladder Adenocarcinoma, and HER2 Negative Breast Cancer. Ms. Cullingford is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
295 Varnum Ave, Lowell, MA 01854
Constance Roche is a Nurse Practitioner in Boston, Massachusetts. Ms. Roche is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer and HER2 Negative Breast Cancer.
The General Hospital Corporation
Erin Sullivan is a Nurse Practitioner in Boston, Massachusetts. Ms. Sullivan is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are BRCA Positive Breast Cancer and HER2 Negative Breast Cancer.
York Hospital
Rebecca Freligh is a Nurse Practitioner in York, Maine. Ms. Freligh has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Smoldering Multiple Myeloma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerMs. Cullingford isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Experienced
- BRCA Positive Breast CancerMs. Cullingford isExperienced. Learn about BRCA Positive Breast Cancer.
- Gallbladder AdenocarcinomaMs. Cullingford isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gastroesophageal Junction CancerMs. Cullingford isExperienced. Learn about Gastroesophageal Junction Cancer.
- HER2 Negative Breast CancerMs. Cullingford isExperienced. Learn about HER2 Negative Breast Cancer.
- Muscle Invasive Bladder CancerMs. Cullingford isExperienced. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerMs. Cullingford isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.
